LOGIN  |  REGISTER
Chimerix

KindlyMD to Participate in H.C. Wainwright’s 26th Annual Global Investment Conference on September 9-11, 2024

August 26, 2024 | Last Trade: US$0.97 0.06 -5.83

SALT LAKE CITY, UT / ACCESSWIRE / August 26, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, is pleased to announce that KindlyMD CEO, Tim Pickett, will participate in H.C. Wainwright's 26th Annual Global Investment Conference being held at the Lotte New York Palace Hotel in New York City on September 9-11, 2024.

Mr. Pickett will present virtually, as well as take part in one-on-one investor meetings during the conference.

H.C. Wainwright 26th Annual Global Investment Conference
Date: September 9-11, 2024
Time: Presentation available on demand from 7:00 a.m. ET
Location: Lotte New York Palace Hotel, New York
Speaker: Tim Pickett, CEO
Webcast: https://journey.ct.events/view/c4d3d1ce-2ac4-43a6-ac75-8ff358a8f3d9

To schedule a one-on-one investor meeting with Mr. Pickett, please contact your H.C. Wainwright representative or KCSA Strategic Communications at This email address is being protected from spambots. You need JavaScript enabled to view it..

A replay of this presentation will be available for at least 90 days following the date of the presentation on the Company's website at https://investors.kindlymd.com/events-presentations.

About KindlyMD

KindlyMD™️ is a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies to offer patients comprehensive care and reduce the addiction and dependency of opioid use in the U.S. KindlyMD currently operates four centers including the largest alternative pain treatment center in Utah. With a focus on holistic pain management through its specialty outpatient clinical services, including, where appropriate, the recommendation of medical cannabis by KindlyMD healthcare providers, KindlyMD is providing better patient health outcomes.

For more information, please visit www.kindlymd.com.

Investor Relations Contact:

Valter Pinto, Managing Director
KCSA Strategic Communications
(212) 896-1254
This email address is being protected from spambots. You need JavaScript enabled to view it.

Stock Quote

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

Featured Stock

Amneal Pharmaceuticals

Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB